Dr. Schiopu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1120 15th Street
Augusta, GA 30912Phone+1 706-721-2273- Is this information wrong?
Education & Training
- Detroit Medical Center/Wayne State UniversityFellowship, Rheumatology, 2003 - 2005
- University of Medicine and Pharmacy ‘Gr T Popa” Iasi Class of 1997
Certifications & Licensure
- GA State Medical License 2022 - 2025
- MI State Medical License 2002 - 2025
- NJ State Medical License 2005 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.Khanna, D., Kramer, F., Höfler, J., Ghadessi, M., Sandner, P., Allanore, Y., Denton, C., Kuwana, M., Matucci-Cerinic, M., Pope, J., Atsumi, T., Bečvář, R., Czirják, L....> ;Rheumatology. 2024 Mar 9
- Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.Schessl, J., Bata-Csörgő, Z., Griger, Z., Moiseev, S., Vencovský, J., Beckmann, I., Clodi, E., Levine, T., , Aggarwal, R., Charles-Schoeman, C., Dimachkie, M., Oddis, ...> ;Arthritis Research & Therapy. 2024 Jan 17
- 1 citationsRiociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial.Oliver Distler, Yannick Allanore, Christopher P Denton, Masataka Kuwana, Marco Matucci-Cerinic, Janet E Pope, Tatsuya Atsumi, Radim Bečvář, László Czirják, Eric Hachul...> ;The Lancet. Rheumatology. 2023 Nov 1
- Join now to see all
Press Mentions
- We Know Too Little About Vaccines in Patients with Inflammatory DiseasesApril 14th, 2023
- Diagnosing & Caring for Patients with FibromyalgiaMay 19th, 2022
- Upadacitnib for RA: Researchers Compared Upadacitinib with Placebo & Adalimumab in Patients with RA & an Inadequate Response to MethotrexateMarch 9th, 2021
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- University of Michigan Medical CenterAnn Arbor, Michigan
- Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
- WellStar MCG Health, affiliated with Medical College of GeorgiaAugusta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: